Ultrafiltration versus diuretics in congestive heart failure

American Journal of the Medical Sciences

Volumn 340, Issue 1, 2010, Pages 38-41

  Flessner, Michael F ^a   Zsom, Lajos ^a   Juncos, Luis ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; FUROSEMIDE; INOTROPIC AGENT; LOOP DIURETIC AGENT; MANNITOL; METOLAZONE; SPIRONOLACTONE; VASODILATOR AGENT; VASOPRESSIN RECEPTOR ANTAGONIST;

ADD ON THERAPY; ADULT; ANASARCA; ARTIFICIAL VENTILATION; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; CARDIORENAL SYNDROME; CASE REPORT; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CONTINUOUS HEMOFILTRATION; CONTINUOUS INFUSION; CREATININE BLOOD LEVEL; DRUG DOSE TITRATION; ENDOTRACHEAL INTUBATION; GLOMERULUS FILTRATION RATE; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE FIBROSIS; HUMAN; HYPERVOLEMIA; HYPOXIA; INTENSIVE CARE UNIT; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY INJURY; MALE; MEAN ARTERIAL PRESSURE; PATHOPHYSIOLOGY; RENAL REPLACEMENT THERAPY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM RESTRICTION; ULTRAFILTRATION; URINE VOLUME;

EID: 77954637791     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181e5916f     Document Type: Conference Paper

References (22)

1. Schrier RW. Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor? J Am Coll Cardiol 2006;47:1-8.
2. Givertz MM. Underlying causes and survival in patients with heart failure. N Engl J Med 2000;342:1120-1122
3. Ronco C, McCullough P, Anker SD, et al. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J 2010;31:703-711
4. Fonarow GC. Heart failure: recent advances in prevention and treatment. Rev Cardiovasc Med 2000;1:25-33, 54.
5. Dries DL, Exner DV, Domanski MJ, et al. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 2000;35: 681-689
6. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 1992;327: 669-677
7. Kenchaiah S, Davis BR, Braunwald E, et al. Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: insights from the Survival and Ventricular Enlargement Trial. Am Heart J 2004;148:356-364
8. Hussain Z, Swindle J, Hauptman PJ. Digoxin use and digoxin toxicity in the post-DIG trial era. J Card Fail 2006;12:343-346
9. Udani SM, Murray PT. The use of renal replacement therapy in acute decompensated heart failure. Semin Dial 2009;22:173-179
10. Bayliss J, Norell M, Canepa-Anson R, et al. Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J 1987;57:17-22.
11. Kramer BK, Schweda F, Kammerl M, et al. Diuretic therapy and diuretic resistance in cardiac failure. Nephrol Dial Transplant 1999; 14(suppl 4):39-42. (Pubitemid 29358865)
12. Ellison DH. Diuretic therapy and resistance in congestive heart failure. Cardiology 2001;96:132-143
13. Neuberg GW, Miller AB, O'Connor CM, et al. Diuretic resistance predicts mortality in patients with advanced heart failure. Am Heart J 2002;144:31-38
14. Wilcox CS. New insights into diuretic use in patients with chronic renal disease. J Am Soc Nephrol 2002;13:798-805.
15. Hasselblad V, Gattis Stough W, Shah MR, et al. Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur J Heart Fail 2007;9:1064-1069
16. Mielniczuk LM, Tsang SW, Desai AS, et al. The association between high-dose diuretics and clinical stability in ambulatory chronic heart failure patients. J Card Fail 2008;14:388-393
17. Costanzo MR, Guglin ME, Saltzberg MT, et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007;49:675-683
18. Selektor Y, Weber KT. The salt-avid state of congestive heart failure revisited. Am J Med Sci 2008;335:209-218
19. Kazory A, Ross EA. Ultrafiltration for decompensated heart failure: renal implications. Heart 2009;95:1047-1051
20. Kazory A, Ejaz AA, Ross EA. Ultrafiltration for heart failure: how fast should we move? Am Heart J 2009;157:205-207
21. Kazory A, Ross EA. Contemporary trends in the pharmacological and extracorporeal management of heart failure: a nephrologic perspective. Circulation 2008;117:975-983
22. Liang KV, Hiniker AR, Williams AW, et al. Use of a novel ultrafiltration device as a treatment strategy for diuretic resistant, refractory heart failure: initial clinical experience in a single center. J Card Fail 2006;12:707-714